Hypertroponinemia, in the context of acute ischemic stroke, without concurrent myocardial infarction was associated with structural cardiac disease and long-term mortality, according to a study featuring admissions data from the International Classification of Diseases, Ninth Edition, and published in Stroke. Read more >>>
Low socioeconomic status may be associated with substantial reductions in life expectancy and should be regarded as a major risk factor for ill health and early death in national and global health policies, according to a study in The Lancet . Authors suggest that both socioeconomic adversity and risk factors for non-communicable diseases should be targeted by health strategies. Read more >>>
In an observed population of patients with cardiovascular disease and a high prevalence of hypertension, very low blood pressure achieved through treatment was associated with increased risks of death or hospital admission for heart failure, according to research published in The Lancet . Read more>>>
Nonischemic dilated cardiomyopathy patients do not appear to benefit from additional primary prevention implantable cardioverter-defibrillator therapy in the setting of heart failure patients with cardiac resynchronization therapy indication when compared to those with ischemic cardiomyopathy, according to research published in the Journal of the American College of Cardiology, in which observational multicenter consortium data network from France, Sweden and the United Kingdom was queried. Read more >>>
The use of sacubitril/valsartan was beneficial in treating heart failure patients due to reduced ejection fraction when compared with enalapril, according to PARADIGM-HF trial results presented at ACC.17. Sacubitril/valsartan was associated with a reduction in CV death and hospitalization for heart failure and a slowed progression of heart failure. Read more >>>
Treatment with a sodium glucose cotransporter-2 inhibitor was associated with reductions in heart failure hospitalizations when compared with treatment with other glucose-lowering drugs, according to six-country, real-world study presented during ACC.17. Read more >>>
The Tsimane, a population indigenous to the Bolivian Amazon, have the lowest reported levels of vascular ageing for any population studied, according to research presented during ACC.17. Findings suggest the loss of subsistence diets and lifestyles in contemporary society could be a risk factor for heart disease. Read more >>>
Prevalence of type-1 Brugada electrocardiogram pattern is higher in central Thailand than other Asian countries, according to research published in the Journal of the American College of Cardiology. Some clinical manifestations of Brugada syndrome include ventricular fibrillation and tachycardia, sudden cardiac death, syncope and chest pain. Read more >>>
A randomized trial exploring the efficacy of various dietary interventions for improving body weight and cardiovascular disease was recently published in the Journal of the American College of Cardiology. Authors found that the retention of participants was higher in interventional programs in which food was provided, however, this only moderately increased participants’ increased intake of recommended foods. Read more >>>
Patients with lower systolic blood pressure (SBP) may obtain greater absolute benefits from treatment with the angiotensin receptor-neprilysin inhibitor sacubitril/valsartan when compared to patients with a higher SBP according to a study published in European Heart Journal. However, these greater benefits may come at the expense of more hypotension-related adverse events. Read more >>>
Adherence to a healthy lifestyle would substantially lower the burden of cardiovascular disease in China, according to research published in the Journal of the American College of Cardiology. The study revealed that factors like current smoking status, alcohol consumption, rate of physical activity and diet were independently associated with risk of major coronary events and ischemic stroke. Approximately 68% of major coronary events and 39% of the ischemic stroke cases observed were attributable to poor adherence to healthy lifestyle. Read more >>>
Authors observed long-term beneficial effects on outcome in patients after myocardial infarction (MI) with nonobstructive coronary arteries (MINOCA) following treatment with statins and angiotensin-converting enzyme inhibitors/angiotensin-receptor blockers (ACEI/ARBs), a trend toward a positive effect following beta-blocker treatment, and a neutral effect following dual antiplatelet therapy, in a study published in Circulation. These data support the use of statins, and ACEI/ARBs for patients who have been diagnosed with MI and MINOCA. Read more >>>
In a study exploring the effects of combination therapy with benznidazole and posaconazole in T. cruzi carriers, authors observed no advantages with combined therapy when compared to benznidazole monotherapy. The study, published in the Journal of the American College of Cardiology, reports that among individuals with chronic asymptomatic T. cruzi infection, posaconazole had significant short-term trypanostatic therapy; however, this effect was not sustained. Monotherapy with benznidazole was superior to posaconazole monotherapy, and achieved conversion of T. cruzi in all subjects on treatment by 30 days, which was sustained for at least one year. Read more >>>
The Journal of the American College of Cardiology published a study exploring changes in the characteristics of atrial fibrillation (AF) patients since the 2011 introduction of nonvitamin K antagonist oral anticoagulants (NOACs). Authors concluded that NOACs have been widely adopted for stroke prevention in newly diagnosed nonvalvular AF patients, however, undertreatment (no therapy or use of antiplatelet therapy only) was common in both North America and Asia. Notably, a significant proportion of new AF patients are electing to use vitamin K antagonists, a sign that warfarin will continue to have an important role for stroke prevention in AF for years to come. Read more >>>
Cardiologists need to join the sleep community in completing clinical trials evaluating the treatment of obstructive sleep apnea (OSA) among patients at risk for developing cardiovascular disease (CVD), as well as patients with symptomatic CVD. The Journal of the American College of Cardiology published a list of key points in response to a review of the cardiovascular consequences of OSA, including mechanisms linking OSA and CVD and various treatment strategies for OSA. Read more >>>
A genetic predisposition to higher waist-to-hip ratio (WHR) was associated with increased risk of type 2 diabetes mellitus and coronary heart disease (CHD), according to a study published in the Journal of the American Medical Association. Elevated WHR has been associated with atherosclerosis severity and myocardial infarction in several studies, although the degree to which elevated WHR directly influences CHD is unknown. This study provides support for a direct relationship between elevated WHR and CHD, and suggests that therapeutic targeting of pathways that influence distribution of body fat may reduce risk for diabetes mellitus and CHD. Read more >>>
First trimester screening has a significant impact on the spectrum of congenital heart defects (CHD) and on the outcomes of pregnancies with CHD diagnosed in the second trimester, according to a retrospective review performed in Southern Monrovia and published in Circulation. Early detection of severe forms of CHD and significant comorbidities resulted in an increased pregnancy termination rate in the first trimester. Read more >>>
Flu and pneumonia vaccines may improve the quality of life and outcomes of heart failure (HF) patients by providing cost-effective protection against life-threatening respiratory infections, according to a review paper published in JACC: Heart Failure. Influenza and pneumococcal pneumonia are two common infectious conditions with significant associated morbidity and mortality. Vaccination could serve as a low-cost intervention preventing the significant system-wide cost associated with heart failure (HF). Large-scale, clinical trial data are limited in determining the true risks and benefits of vaccination specifically in the HF population. Read more >>>
Stroke is an uncommon, but measurable, presenting feature of atrial fibrillation according to a study published in Stroke. The authors found that their data suggest that emphasizing cost-effectiveness and population-wide atrial fibrillation screening efforts could improve population-level stroke rates. Read more >>>
The ACC, in partnership with Pfizer, launched the webinar component of its Global Education Program on Heart Disease Prevention in Russia on Feb. 20 with an educational webinar, titled "The Problem of Atherosclerosis and Related Heart Disease." Read more >>>
Intensive blood pressure (BP)-lowering treatment decreased major adverse cardiovascular events in older hypertensive patients, according to a study published in the Journal of the American College of Cardiology. However, intensive BP lowering increased risk of renal failure. The authors said, "It appears that in older patients, the cardiovascular benefit of intensive therapy may come at the expense of increase in adverse events, and clinicians should carefully consider risk versus benefit for the individual patient." Read more >>>
According to a study published in Lancet, the delivery of personalized risk information accompanied by a customized invitation for an introductory Stop Smoking session more than doubled the odds of smokers attending the session when compared with the standard generic invitation to contact one of England's National Health Service Stop Smoking Service centers. This research supports the use of tailored messaging to smokers to initiate participation in smoking cessation programs. Read more>>>
The reduction of socioeconomic inequalities in cardiovascular disease outcomes may require different approaches for men and women, according to a systematic review and meta-analysis published in the Journal of Epidemiology and Community Health. The data suggest that women with lower levels of education may be at increased risk for adverse outcomes, but efforts to reduce these disparities will likely improve cardiovascular health across all genders. Articles included in this analysis were sourced from Asia, Europe, North America and Australasia. Read more >>>
A healthy lifestyle may not be associated with a lower risk of adverse stroke outcomes, according to a study published in Stroke. A total of 82,597 patients presenting with acute stroke were identified using the Danish Stroke Registry. An unhealthy lifestyle did not increase the risk of severe stroke, in-hospital pneumonia or urinary tract infection, but being underweight was associated with a higher 30-day mortality for men and women. Read more >>>
The 9th Cardiovascular Conference on the Middle East – held one day before ACC.17 on March 16 – will focus on the challenges and opportunities of improving heart health in the region. Read More >>>
The cover story in the latest issue of Cardiology magazine looks at the trends some leading experts anticipate will affect cardiovascular medicine in the year ahead. Read More >>>
The ACC is the professional home for more than 52,000 cardiovascular care professionals around the world. Read More >>>
Building on the 2016 success of pilot conferences in Latin America and the Middle East, the College will expand the International Regional Conference Program to include an Asia Pacific conference, held Dec. 1 – 3, 2017, in Shanghai, China. The 2017 program will also include innovative educational conferences in Mexico City, Mexico, held June 22 – 24, and Dubai, UAE, held Oct. 19 – 21. Read More >>>
In recent decades, rates of diabetes in China have significantly increased. A study published Jan. 17 in the Journal of the American Medical Association reports that, among all adults in China, diabetes was associated with increased mortality due to a range of cardiovascular and non-cardiovascular diseases... Read More >>>
Leaders in health care from across the globe recently traveled to ACC’s Heart House headquarters in Washington, DC, for the 3rd Annual International Leadership Academy. Read More >>>
The ACC Chapter Exchange program recently established three new partnerships between Mexico and Arizona; Greece and New Jersey; and Argentina and New York. Read More >>>
In October, ACC held its inaugural Regional Conferences in Mexico City, Mexico, and Jeddah, Saudi Arabia. The two conferences were overwhelmingly successful, collectively attracting over 1,000 attendees. Read More >>>
ACC President, Richard A. Chazal, MD, FACC, will lead an ACC delegation to the 27th Great Wall International Congress of Cardiology from October 13-16, in Beijing, China. There will be three joint sessions on Advances in Cardiac Imaging in 2016, Geriatric Cardiology: Are We Prepared For the Tsunami?, and ACCi2@GWICC.... Read more >>>
The cover story in the latest issue of Cardiology magazine offers a historical look at the concept of medical professionalism, as well as resources from the ACC for cardiovascular professionals. This issue also highlights new appointments in global health, how the ACC is shaping the future of global health, and the Stepathlon CV Health Study showing how interactive, mobile-based health approaches...Read more >>>
For the 13th year, the ACC held a broadcast of Annual Scientific Session highlights to a live audience of 3,500 cardiovascular physicians across China.
ACC President, Richard A. Chazal, MD, FACC, recently authored a perspective piece titled, “China may hold answers to addressing cardiovascular disease epidemic,” published in the April issue of the Journal of Translational Internal Medicine.
This year the ACC will hold a joint session with the American Heart Association (AHA) during the World Congress of Cardiology & Cardiovascular Health (WCC) in Mexico City, Mexico, June 4–7.
The second editorial board meeting for the Chinese edition online version of the Journal of the American College of Cardiology (JACC): Cardiovascular Interventions was held at the China National Convention Center in Beijing, on March 17.
The ACC continues to be recognized as an international leader in the fight to improve cardiovascular care worldwide through two new key appointments in global health.
The ACC recently partnered with the Chinese Society of Cardiology (CSC) to launch a cardiovascular disease education and awareness program that will prepare physicians and hospital systems for a nationwide health care shift that supports heart disease prevention and optimal patient care.
The ACC continues to play an important role in improving cardiovascular care worldwide. Recently, Valentin Fuster, MD, PhD, MACC, and eleven other ACC faculty attended the Cardiovascular Symposium extended over two days, on Jan. 23 and Jan. 24, in Mumbai, India.
The ACC continues to broaden the reach of its outpatient cardiovascular data registries worldwide. Most recently the ACC partnered with its Mexico Chapter, in collaboration with both the Sociedad Mexicana de Cardiología and the Asociación Nacional de Cardiólogos de México, to establish a registry network that is aligned with the PINNACLE Registry.
Colombia recently became ACC’s 35th International Chapter, making it the second ACC Chapter in Formation to become a full-fledged Chapter.
The majority of ACC International Fellows in Training (FITs) are both very/extremely familiar with the College and very/extremely satisfied, according to a recent ACC survey of International FIT members. Satisfaction was highest among FITs in the Asia Pacific region (86 percent), as well as in the South America/Central America/Caribbean region (80%).
Earlier this year, Serbia and the Republic of Srpska became ACC's 34th full-fledged International Chapter. Before meeting all necessary requirements to officially become a Chapter, it was ACC's first International Chapter in formation, working towards increasing its membership to meet the 20 FACC threshold required to become a complete Chapter...
Next month, the American College of Cardiology will support the Top to Toe Transcatheter Solutions Conference, 4TS in collaboration with our ACC UAE Chapter...
Next April, a delegation of ACC faculty led by President-Elect Kim Williams, MD, FACC will present prevention and heart failure highlights from ACC.15 at the 20th Asia Pacific Society of Cardiology Congress...
In September, the ACC International Affairs team and SUN Pharma partnered to bring the Best of ACC.14 educational programs to more than 1,400 physicians and cardiovascular care team members in South East Asia. This is the eighth year of the very successful ACC and SUN Pharma, "BEST OF ACC" collaboration. ACC Faculty provided the latest practice innovations, new techniques and recent research findings directly to the physicians and cardiac care teams in Chennai and Mumbai, Kathmandu in Nepal and Dhaka in Bangladesh...